000 | 01884 a2200469 4500 | ||
---|---|---|---|
005 | 20250516202034.0 | ||
264 | 0 | _c20140610 | |
008 | 201406s 0 0 eng d | ||
022 | _a1530-0307 | ||
024 | 7 |
_a10.1038/labinvest.2014.42 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aTang, Youcai | |
245 | 0 | 0 |
_aCurcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signaling. _h[electronic resource] |
260 |
_bLaboratory investigation; a journal of technical methods and pathology _cMay 2014 |
||
300 |
_a503-16 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 | _aChromones |
650 | 0 | 4 | _aCurcuma |
650 | 0 | 4 |
_aCurcumin _xpharmacology |
650 | 0 | 4 |
_aGene Expression Regulation _xdrug effects |
650 | 0 | 4 |
_aGlycation End Products, Advanced _xantagonists & inhibitors |
650 | 0 | 4 |
_aHepatic Stellate Cells _xdrug effects |
650 | 0 | 4 |
_aLeptin _xantagonists & inhibitors |
650 | 0 | 4 |
_aLiver Cirrhosis _xprevention & control |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred C57BL |
650 | 0 | 4 | _aMorpholines |
650 | 0 | 4 |
_aPlant Extracts _xpharmacology |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 | _aReceptor for Advanced Glycation End Products |
650 | 0 | 4 |
_aReceptors, Immunologic _xmetabolism |
650 | 0 | 4 |
_aReceptors, Leptin _xmetabolism |
650 | 0 | 4 | _aTyrphostins |
700 | 1 | _aChen, Anping | |
773 | 0 |
_tLaboratory investigation; a journal of technical methods and pathology _gvol. 94 _gno. 5 _gp. 503-16 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/labinvest.2014.42 _zAvailable from publisher's website |
999 |
_c23626250 _d23626250 |